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Abstract 
Sensory neurons of the dorsal root ganglia (DRG) are the primary responders to stimuli 
inducing feelings of touch, pain, temperature, vibration, pressure and muscle tension. They 
consist of multiple subpopulations based on their morphology, molecular and functional 
properties. Our understanding of DRG sensory neurons has been predominantly driven by 
rodent studies and using transformed cell lines, whereas less is known about human sensory 
DRG neurons simply because of limited availability of human tissue. Although these previous 
studies have been fundamental for our understanding of the sensory system, it is imperative to 
profile human DRG subpopulations as it is becoming evident that human sensory neurons do 
not share the identical molecular and functional properties found in other species. Furthermore, 
there are wide range of diseases and disorders that directly/indirectly cause sensory neuronal 
degeneration or dysfunctionality. Having an in vitro source of human DRG sensory neurons is 
paramount for studying their development, unique neuronal properties and for accelerating 
regenerative therapies to treat sensory neuropathies. Here we review the major studies 
describing generation of DRG sensory neurons from human pluripotent stem cells and 
fibroblasts and the gaps that need to be addressed for using in vitro-generated human DRG 
neurons to model human DRG tissue. 
 
  
Introduction 
The fundamental purpose of the sensory nervous system is to receive and transmit 
information from skin, muscle and sensory organs to the brain, which initiates how we interpret 
our external and internal world and consequently influences what response will be made. The 
sensory nervous system includes the visual, auditory and olfactory systems as well as the 
peripherally located cranial sensory and dorsal root ganglia (DRG). The DRG consists of a 
multitude of sensory neuronal subtypes that function to relay sensory stimuli, including 
temperature, pressure, pain and position to the central nervous system. 
Not surprisingly, there are vast ranges of diseases and conditions (Melli and Höke, 
2009), usually progressive, which can affect DRG sensory neurons. The underlying causes of 
DRG degeneration may be either directly intrinsic to DRG neurons or indirectly associated 
with other pathologies. Some inherited genetic diseases inducing DRG degeneration include  
Friedreich’s Ataxia (Delatycki and Corben, 2012) and Charcot Marie Tooth Disease 
(d’Ydewalle et al., 2012). Other conditions that may affect DRG neuronal functionality are 
autoimmune disease (Sederholm, 2010), infections (such as AIDS) (Schütz and Robinson-
Papp, 2013) or unknown idiopathic conditions (de Schryver et al., 2011). DRG degeneration 
is also observed in cases relating to drugs (Manji, 2011) and alcohol toxicity (Chopra and 
Tiwari, 2012).  DRG neurons can also be severely damaged by physical trauma (Lim et al., 
2015). People affected by DRG peripheral neuropathy report different symptoms, including 
mild to chronic pain, loss of feeling and intense itchiness. Such symptoms can be severely 
debilitating depending on the nature and cause. Often the degeneration is progressive and, for 
some conditions, treatments are geared to damping the symptoms and slowing progression of 
nerve damage. In many cases, there is no treatment available. Having an in vitro source of 
human sensory neurons would be invaluable for developing neuroregenerative therapies to 
treat specific neuropathies. 
 
Classification of DRG sensory neurons 
Somatosensory neurons of the DRG are traditionally classified into three sub-
populations: nociceptors, mechanoreceptors and proprioceptors. This classification is based on 
characteristics relating to their function and morphological features such as cell body size, axon 
diameter, degree of myelination, types of afferent endings and the laminar targets of their 
efferent terminals in the spinal cord (Kandel et al., 2013). However, studies conducted on 
transgenic mice and more sophisticated molecular techniques have provided a breakthrough in 
this field, revealing a more complex and subtle diversity among these three subpopulations. 
Emerging new knowledge enables the possibility to improve the traditional classification and 
adopt new criteria to classify the somatosensory neurons based on in-depth transcriptional 
profiling matched with functional analyses. A general overview of the three major classes of 
DRG sensory neurons are: 
Nociceptive neurons respond to painful or pruritic (itch) stimuli and thermoception 
(Dubin and Patapoutian, 2010; Zhang and Bao, 2006). They innervate peripheral tissues such 
as cutaneous epithelial tissue, as well as muscle and other internal organs, where molecular 
receptors located on sensory terminals react to noxious stimuli (Proske and Gandevia, 2012). 
They are classified as small diameter (<30 µm) and can be distinguished several subtypes 
depending on the rate of myelination: unmyelinated (C) or lightly myelinated (Aδ) fibres. 
Unmyelinated C fibre neurons are characterized by slow conductivity (~2m/s) and are able of 
responding to different combination of stimuli, including temperatures, pruritogens, tissue 
damage, chemical irritants (Laing and Dhaka, 2016). Myelinated Aδ fibre neurons have faster 
conduction (up to 30m/s) and, as consequence of this property, are specialized for detecting 
localized fast pain, repeated stimulation as well as tissue injury (Laing and Dhaka, 2016). The 
neurotrophic receptor expressed by nociceptors is TrkA, that has high affinity for Nerve 
Growth Factor (NGF). There is a smaller population of nociceptive neurons that transiently 
express TrkA during development, and eventually express Ret (Luo et al., 2007). Nociceptors 
are predominantly excitatory neurons and release glutamate as their primary neurotransmitter. 
They can be further sub-classified into peptidergic and non-peptidergic neurons. Peptidergic 
nociceptive neurons release neuropeptides such as substance P or calcitonin gene related-
peptide (CGRP), instead non-peptidergic neurons are identified by the expression of isolectin 
IB4 (a histological marker) (Mandge and Manchanda, 2015). 
 Proprioceptive neurons transmit information about conscious sensations, such as limb 
position, balance and movement. They consist of large (12-20µm) and medium (6-12µm) 
diameter myelinated A fibres (Aα, Ab). Proprioceptors express TrkC neurotrophic receptors, 
activated by Neurotrophin 3 (NT-3) (Fariñas et al., 1998; Henion et al., 1995; Liebl et al., 1997; 
Tessarollo et al., 1997). Due to their degree of myelination and diameter size, they have a fast 
conduction velocity (72-120 m/s for large proprioceptors and 30-70m/s for medium ones) (Le 
Pichon and Chesler, 2014). Proprioceptors innervate specialised organs called Golgi tendon 
organs and muscle spindle. They function to sense muscle tension, contraction and limb 
position. Their efferent projections mostly end in laminae III-V of the spinal cord. However, 
some also make connections in deeper laminae in order to communicate with motor neurons 
of reflex circuits (Le Pichon and Chesler, 2014). 
 Mechanoreceptors innervate skin tissue and detect cutaneous touch sensation and 
vibrational stimuli. Most mechanoreceptor fibres are large diameter (Ab) (Abraira and Ginty, 
2013; Le Pichon and Chesler, 2014) myelinated and usually distinguished by their expression 
of TrkB receptor which has high affinity for Brain-derived growth factor (BDNF) (Shimizu et 
al., 2007). Mechanoreceptors project to the dermal and epidermal regions of the skin and 
function to detect mechanical stimuli via specialised mechanosensory end organs such as 
Meissner’s corpuscles, Pacinian corpuscles, Ruffini corpuscules and Merkel cell endings 
(Fleming and Luo, 2013; Gilman, 2002; Zimmerman et al., 2014). 
 These classification systems have served well but with the advent of better molecular 
techniques we know that they may not adequately cover the true diversity or the lineage origin. 
New emerging studies using single cell gene expression profiling of adult rodent DRGs have 
identified novel subpopulations, as well as re-defined gene expression profiles of more 
commonly known populations (Li et al., 2017, 2016; Usoskin et al., 2015). To date most of the 
molecular and functional profiling of sensory DRG subclasses has been driven by animal 
studies and less is known about human DRG neurons. The few studies describing human DRG 
sensory neurons show inconsistencies in molecular and functional properties compared to that 
described in the rodent. Some examples include: P2X3 receptors that are involved in mediating 
chronic pain show different potencies in their response to antagonists between rodent and 
primate DRG neurons (Serrano et al., 2012); pharmacological agents that effectively block 
GABAA receptor currents in rodent DRG neurons are not effective in human DRGs (Valeyev 
et al., 1996); the family of mas-related G-protein-coupled receptors (MRGPRS) associated 
with nociceptor neurons consist of 4 genes in the human genome but over 30 genes within the 
mouse genome (Zylka et al., 2003); there are differences in the proportion of DRG neurons 
that co-express TRPV1/TRKA and RET/TRKA between adult human and mouse DRG tissue 
(Rostock et al., 2017); NF200 expression is detected in most human DRG neurons but only in 
a subset of mouse DRGs (Rostock et al., 2017). These studies and others strongly highlight the 
need to work with human sensory neurons, particularly for screening candidate pharmaceutical 
compounds that modulate adverse sensations, such as chronic pain.  
  
 
 
Human sources of dorsal root ganglia sensory neurons  
 There is a strong need to obtain an in vitro source of human sensory neurons to study 
their unique molecular and functional profiles, myelination properties, regenerative capacities 
and, in particular, for establishing high through-put drug screening platforms. Whilst there are 
reports describing human sensory neurons derived from human DRG tissue (Davidson et al., 
2014; Rostock et al., 2017; Valtcheva et al., 2016; Zhang et al., 2017), this source is impractical 
for many laboratories. With the discovery of human pluripotent stem cells (hPSC), it is now 
feasible to derive human sensory neurons in abundance and minimize the need to access human 
DRG tissue for advancing therapies and knowledge about the human sensory system. The 
review below details some of the major studies describing generation of human DRG neurons 
from hPSC, outlining the approaches used, characterization of the neurons and their 
applications. An alternative approach, whereby sensory neurons are generated directly from 
human fibroblasts, is also described. 
                                                               
Human pluripotent stem cells 
Pluripotent stem cells are stem cells that have the ability to differentiate to all cell types 
of body.  There are two different avenue by which human pluripotent stem cells (hPSC) can be 
generated; (a) from embryos (human embryonic stem cells, hESC), and (b) via genetic 
reprogramming of somatic cells to induce pluripotent stem cells (iPSC) (Hirschi et al., 2014; 
Takahashi and Yamanaka, 2006).  IPSC technologies have allowed the possibility of modifying 
patient-derived cells to regain their plasticity and pluripotency, which can then be used to 
generate the appropriate cell type for that disease. For this reason, in the last decade, medical 
research is focused on the possible application of iPSC in regenerative medicine, using iPSC 
disease models for elucidating disease pathologies and drug discovery research.  
 To date there have been two main approaches for deriving sensory neurons from hPSC 
(Figure 1). One approach is to recapitulate stages of DRG embryonic development in the 
culture dish, whereby hPSC are initially differentiated to neural crest progenitors followed by 
their subsequent differentiation to DRG neurons. The second approach is to direct hPSC 
differentiation to mature functional sensory neurons, bypassing the progenitor stage. Both 
systems have their pros and cons, which are outlined below. 
 
HPSC differentiation to mixed populations of DRG sensory neurons 
 Developmentally, all DRG neurons arise from neural crest progenitor cells that migrate 
from the embryonic dorsal neural tube to the presumptive DRG regions and upregulate 
expression of Islet1/2 and Brn3A (Dykes et al., 2011; Raible and Ungos, 2006). There are 
numerous publications describing hPSC differentiation to neural crest (Table 1) and include 
evidence of DRG sensory neuronal differentiation as demonstrated by co-expression of 
BRN3A and ISLET1 (Alshawaf et al., 2018; Brokhman et al., 2008; Deng et al., 2014; Denham 
et al., 2015; Dykes et al., 2011; Goldstein et al., 2010; Hoelting et al., 2016; Lee et al., 2012). 
This included studies from our laboratory describing efficient generation of neural crest from 
hPSC using small molecule inhibitors of activin/nodal and GSK3b signalling pathways, 
SB431542 and CHIR99021, respectively, followed by treatment with bone morphogenetic 
protein 2 (BMP2) (Denham et al., 2015). In this same study, we also reported DRG neuronal 
differentiation by culturing neural crest progenitors in media supplemented with BDNF, NT3 
and NGF. Our initial study was not extensive in charactering DRG neuronal subtypes found in 
differentiated cultures but instead showed neurons expressing pan-sensory neuronal markers, 
BRN3A and ISLET1 as well as Peripherin (Denham et al., 2015). This was addressed in a more 
recent report whereby we examined expression of sensory neuronal subpopulation markers in 
the hESC-derived neural crest differentiated cultures (Alshawaf et al., 2018). We identified the 
sensory neuronal cultures consisted of heterogeneous neuronal subtypes, expressing TRKA 
(25%), TRKB (17%) and TRKC (24%) receptors, which are classic markers of nociceptors, 
mechanoreceptors and proprioceptors respectively. Using Usoskin et al.’s (Usoskin et al., 
2015) study as reference, we also examined co-expression of markers to distinguish several 
subtypes of sensory neurons within the same subpopulation. By immunostaining, we observed 
neurons double positive for TRKB and NECAB2 as well as TRKC and FAM19A1, which 
correspond to different subtypes of mechanoreceptive neurons. In addition, we identified 
different subtypes of nociceptors, peptidergic and non-peptidergic neurons. This included 
neurons co-expressing TRKA and TRPV1 or PLEXIN C1 and somatostatin, which are found 
in distinct populations of non-peptidergic neurons. Peptidergic neurons expressing TRKA and 
FAM19A1 or TRKA and TAC1 were also detected. Characteristic markers of proprioceptive 
neurons, such as Osteopontin and Parvalbumin, were also found within the cultures. 
Hetereogeneity within the sensory neuronal cultures was further confirmed by functional 
analyses using multi-electrode arrays, whereby neurons responding to chemical, heat and 
osmotic pressure stimuli were demonstrated (Alshawaf et al., 2018). 
 This report was one of the first to show a multitude of sensory neuronal subclasses 
derived from hPSCs using the same differentiation protocol. Having a differentiation system 
that enables the generation of diverse DRG sensory neuronal populations may be resourceful 
for modelling DRG tissue to study neuronal/neuronal and neuronal/glial interactions between 
different subtypes. It also provides a platform to reveal and characterize sensory neuronal 
populations that may exist within human DRG tissue. Further in-depth analyses, such as single 
cell RNA-sequencing, will provide further insight about the subclasses of sensory neurons 
found within the human DRG and be able to compare this to other species, particularly rodent 
DRGs that are extensively studied.  
 
HPSC differentiation to nociceptors 
Whilst having heterogeneous cultures of sensory neurons may be useful for modelling 
the DRG in its entirety, it is also advantageous to have cultures consisting of homogenous 
sensory neuronal subtypes for performing in-depth phenotypic and functional analyses to 
characterize a specific population.  
The first report describing direct hPSC differentiation to a specific DRG lineage, 
nociceptors, was by Chambers et al. (Chambers et al., 2012). Using a combination of five 
different small molecules, LDN-193189, SB431542, SU5402, CHIR99021, and DAPT, at least 
60% TRKA expressing nociceptors were generated from hPSC. RUNX1 expression supported 
the derivation of peptidergic neurons, which was confirmed by immunostainings for Substance 
P and CGRP. Interestingly, their results revealed a difference between what reported in 
literature about the expression of RUNX1 in mouse DRG sensory neurons and those derived 
by hPSCs (Chambers et al., 2012). RUNX1 expression was found to decrease at later stages of 
differentiation, whereas in mice, its expression persists in non-peptidergic neurons (Huang et 
al., 2015; Samad et al., 2010). Nociceptive identity in hPSC differentiated cultures was also 
supported with functional studies, demonstrating functional expression of SCN10A sodium 
channels and neuronal responsiveness to capsaicin and a,b Methylene-ATP, which mimic 
inflammatory pain. Interestingly, the majority of hPSC-derived nociceptors expressed P2RX3 
rather than TRPV1. 
Chamber’s protocol for deriving nociceptors neurons was adapted by other groups to 
further explore the molecular and functional profiles of hPSC-derived nociceptors. Eberhardt 
et al. (Eberhardt et al., 2015) examined molecular and functional expression of tetradotoxin-
sensitive (TTXs) and TTX-resistant (TTXr) voltage-gated sodium channels (NAVs) in hPSC-
derived nociceptors. Their findings showed that hPSC-derived neurons expressed pan-neuronal 
NAVs, NAV1.1, NAV1.2, and NAV1.6, as well as NAVs specific to peripheral sensory 
neurons, NAV1.8, NAV1.9 and NAV1.5. The expression and electrophysiological properties 
of NAV1.5 within hPSC-derived nociceptors was akin with embryonic rodent DRG neurons, 
indicating their developmental stage. Young et al. (Young et al., 2014) reported comprehensive 
transcriptome profiling of hPSC-sensory nociceptors at the single cell level and at different 
time points during the differentiation allowing them to better define their identity. Of 
significance, the data was compared to human sensory neurons obtained from three different 
adult donors. A significant difference in gene expression emerged between day 16 and 32 of 
hPSC sensory neuronal differentiation compared to human DRG tissue. Authors hypothesized 
that this difference is related to genes that are expressed in myelin-producing Schwann cells 
and infiltrating immune cells found in the human DRG. However, no relevant differences were 
observed at later time points of differentiation, suggesting maturation of hPSC-derived sensory 
neurons. Single cell qPCR analyses examined the degree of heterogeneity in hPSC-derived 
sensory neurons, with a particular focus on specific channels involved in pain sensation. The 
RNA based analyses were supported with matching functional data obtained by patch-clamp 
electrophysiological analyses. These results confirmed presence of functional GABAAR 
(subunits a2, a5, g2), which correspond to those found in human DRG neurons. Isoforms of 
HCN (HCN1), KCNQ2/3 and ASIC (ASIC3) ion channels were also detected in hPSC-derived 
sensory neurons. HCN channels play an important role in regulating the action potential 
frequency in DRG neurons, KCNQ2/3 regulate neuronal resting membrane potential and ASIC 
channels are involved in pain sensation mediated by acidosis.  
Overall, these findings demonstrate key comparisons between hPSC-derived sensory 
neurons and human DRGs. This knowledge helps set up the stage for using hPSC-derived 
sensory neurons to establish drug discovery platforms that target nociceptor populations.  
 
HPSC differentiation to mechanoreceptors 
 Generation of mechanoreceptors from hPSC-derived neural crest was described by 
Schrenk-Siemens and colleagues (Schrenk-Siemens et al., 2015). Their report suggested that 
GDNF treatment, a RET receptor ligand, was sufficient for biasing neural crest differentiation 
to mechanoreceptors. The differentiated cultures consisted of ~2.8% of TRKB positive 
neurons, with detected expression of other specific mechanoreceptor markers including MAF, 
MAFA, and PIEZO2. Few TRKC positive neurons were observed and no expression of TRKA 
or other nociceptor markers were detected. The low percentage of TRKB positive neurons 
highlights the need to develop alternative methods to enrich for specific sensory neuronal 
populations. Relevant to this, the authors demonstrated that forced expression of 
NEUROGENIN2 (NGN2) in hPSC-derived neural crest further increased expression of MAFA 
as well as pan-sensory neuronal markers, ISLET1 and NF200 (Schrenk-Siemens et al., 2015). 
Functional characterization of hPSC-derived mechanoreceptors was investigated by patch 
clamp recordings and calcium imaging. Firing properties of hPSC-derived mechanoreceptors 
were akin to rodent mechanoreceptors, showing functional evidence of Nav1.7 channels, while 
channels typically expressed in nociceptive neurons (such as NAV1.8 and NAV1.9) were 
absent. This study also used CRISP/CAS9 gene-editing to abolish expression of PIEZO2, a 
mechanically activated ion channel, in hPSC to determine its role in mechanoreceptors. The 
authors showed mechanotransduction currents where depleted in the absence PIEZO2 
expression despite persistent expression of other mechanoreceptive markers. These findings 
are significant in showing a critical functional role of PIEZO2 in human mechanoreceptors. 
Such studies also reflect the value of deriving sensory neuronal subtypes from hPSC for 
interrogating ion function in human neurons. 
 
Human sensory neurons derived directly from fibroblasts 
 An alternative to using hPSC as a source for generating human sensory neurons is to 
directly reprogram human fibroblasts to a neuronal fate (Figure 1). In 2015, Blanchard and 
colleagues reported direct conversion of human embryonic and mouse fibroblasts to DRG 
sensory neurons using ectopic expression of key transcription factors associated with DRG 
sensory neuron fate (Blanchard et al., 2015). The neurogenic basic helix-loop-helix protein 
NGN1 and NGN2, play an important role during the lateral migration of embryonic neural 
crest cells from the region between the epidermis and the neural tube to the future DRG regions 
(Blanchard et al., 2015; Hari et al., 2002; Ma et al., 1999) The subsequent expression of 
BRN3A in the neural crest progenitors differentiates the precursors to sensory neurons (Dykes 
et al., 2010, 2011; Eng et al., 2007; Zou et al., 2012). Using a doxycycline (dox)-inducible 
lentiviral vector system, fibroblasts were transduced to exogenously express NGN1/BRN3A 
or NGN2/BRN3A upon drug treatment. At least 90% of fibroblasts were reprogrammed to 
neurons, with either combination of NGN1/BRN3A and NGN2/BRN3A factors, as shown by 
expression of b tubulin III and MAP2ab. Expression of pre-synaptic markers, synaptobrevin 
and synapsin were also detected. Induced neurons were pseudounipolar, a characteristic 
morphological feature of sensory neurons, with a range of different cell body sizes, indicating 
different neuronal subtypes. Molecular markers of peripheral sensory neurons were also 
detected, including NF200, Peripherin, TRKA, TRKB and TRKC. Expression of TRKA, 
TRKB, TRKC were observed in approximately 25-30% of the transduced cultures for each 
receptor. Calcium imaging and patch clamp analyses confirmed that the induced neurons were 
functional. Further functional characterization analyses of nociceptor neuronal subtypes were 
performed using agonists of TRP ion channels, such as capsaicin, menthol and mustard oil, as 
well as pruritogenic stimuli, histamine, chloroquine and SL1GRL.  
 Direct conversion of human and mouse fibroblast to nociceptor neurons was also 
described by Wainger and colleagues (Wainger et al., 2015). Assessing twelve candidate 
transcription factors, the authors identified five of them that were critical for direct 
reprogramming; ASCL1, MYT1L, KLF7, NGN1 and ISL2. The resultant reprogrammed 
cultures consisted of 14% neurons. Conversion to nociceptors was determined using a mouse 
embryonic fibroblast TRPV1 reporter cell line as well as expression of Peripherin, CGRP, 
TRPM8 and TRPA1. Interestingly, the proportion of neurons expressing specific ion channels 
was similar to that identified in primary adult DRG neurons. Functional evidence of ion 
channel expression was also demonstrated using calcium imaging and MEA analyses to 
measure neuronal responsiveness to noxious agonists, menthol, mustard oil and capsaicin. In 
this same study, the authors also generated induced nociceptive neurons from familial 
dysautonomia (FD) fibroblasts and showed reduced neurite outgrowth and branches compared 
to induced nociceptive neurons from healthy controls. This data is proof-of-concept in using 
direct reprogramming methodology to generate patient-derived sensory neurons for modelling 
peripheral sensory neuropathies.   
One main advantage of reprogramming fibroblasts directly to neurons is that it is direct 
and therefore the protocol is potentially less likely to generate heterogeneous cell types, as 
observed with hPSC differentiation. The disadvantage, however, is that fibroblast cell lines 
may have a limited capacity to be maintained in culture. Nevertheless, studies involving direct 
reprogramming are highly informative for determining the combination of transcription factors 
needed to specify DRG sensory neuronal subtypes, which will help pave new approaches in 
generating human sensory neurons in a direct and consistent manner. 
 
Advantages and limitations in using in vitro generated sensory neurons 
One of the major advantages of generating human sensory neurons in vitro, particularly 
from hPSCs, is the capacity to generate high numbers of well-characterized human neuronal 
lineages in a consistent manner. This helps the development of high through-put screening 
assays and significantly reduces experimental animal usage. Another advantage is their use for 
in vitro disease modelling. Examples of these different applications are mentioned below. 
However, there are still significant challenges that need to be addressed before in vitro-
generated human sensory neurons can entirely model human DRG tissue. Such challenges 
include establishing co-culture systems whereby afferent and efferent processes of hPSC-
derived sensory neurons form connections with appropriate target cells, as well as axonal 
myelination of larger sensory neuronal subtypes. In this respect, nociceptors are somewhat 
relatively easier to generate from hPSC since they do not require myelination and can be 
stimulated in the absence of innervating target tissue. Indeed, the literature to date reflects this 
as there are significantly more reports describing generation of nociceptors from hPSC than 
mechanoreceptor and proprioceptor subtypes. 
Other challenges fall back on general issues relating to hPSC biology. It is well 
documented that hPSC show great variability between different cell lines as well as in the 
robustness of the protocol within the same line (Kim et al., 2007; Osafune et al., 2008; Pal et 
al., 2009). Generation of sensory neuronal reporter cell lines may partially address this issue 
whereby specific neuronal cell types can be identified amongst heterogeneous cultures and 
isolated for phenotypic and functional analyses. Saying this, given the complexity of 
phenotypic signature markers it may not be simple to identify a sensory neuronal lineage using 
1-2 markers only. Nevertheless, using reporter cell lines is still a significant start for 
phenotyping major populations based on traditional markers, such as the TRK receptors. 
Another important issue to consider is relying on markers characterized in rodents or other 
species to identify human sensory populations. Ultimately, phenotypic and functional 
characterization of in-vitro generated sensory neurons needs to be compared with human fetal 
and adult DRG tissue as much as possible to determine consistencies. 
  
Applications of hPSC-derived sensory neurons 
 Aside from current limitations associated with hPSC-derived sensory neurons, there is 
significant progress in recent years for their application in disease modelling, drug screening, 
toxicity screening and studying ion channels.  
For high through-put screening of compounds, large numbers of homogeneous 
populations of sensory neurons are needed. The Chambers protocol for deriving nociceptors, 
albeit it is a mixed population of nociceptor subtypes, is appropriate given that it is direct and 
relatively efficient. Indeed, there have been at least a couple of publications that have adapted 
the Chambers method to establish high through-put screening systems of sensory neurons 
(Hoelting et al., 2016; Stacey et al., 2018). Hoelting and colleagues described a high through-
put system for screening potential peripheral toxins (Hoelting et al., 2016). Interestingly, the 
immature state of hPSC-derived sensory neurons was used as an advantage for the screening 
process based on the rationale that growing neurites are more susceptible to peripheral toxins 
than established neurites. Using fully automated live cell microscopy, large numbers of 
compounds were screened for effects on neurite outgrowth and cell viability. This assay, 
known as the ‘PeriTox test’, was trialled against known toxins and also compared with another 
toxicology screening assay. Consistent results were obtained showing proof-of-concept for 
using hPSC-derived sensory neurons for evaluating toxins. The other study, reported by Stacey 
and colleagues, described the application of hPSC-derived sensory neurons for screening 
candidate compounds to treat chronic pain (Stacey et al., 2018). A chemogenomics library 
consisting of 2700 small molecules were screened for their ability to inhibit veratridine-evoked 
excitability in hPSC-derived neurons using a 384-well calcium flux assay. Validation of the 
functional assay was also performed. Both studies demonstrate the capability of using hPSC-
derived sensory neurons for large scale screens, although the differentiation protocols needed 
to be adapted to make it accessible and practical for multi-well systems. For example, both 
papers mentioned benefits of cryopreserving neurons for scaling up cell numbers prior to their 
use. Also, in addition to the differentiation protocol, the assay readout needs to be robust and 
reliable. Overall, these studies published to date are promising for using hPSC-derived sensory 
neurons to establish platforms with multi-purpose capabilities and large-scale screening 
capacities.   
Complimentary to establishing high through-put screens, hPSC-derived sensory 
neurons are also purposeful for studying human ion channel function in both normal wild type 
and mutant states. Prior to hPSC technology, many studies used the approach of expressing 
human ion channels in oocytes or mammalian cell lines to characterize their pharmacological 
activities (Rosenbaum et al., 2002; Sangameswaran et al., 1996; Trezise et al., 1998). A 
significant step forward was the development of methods to transfect rodent primary neurons 
with human ion channels, thereby using a more appropriate cell type to study downstream 
pathways of ion channel activation/silencing (Dib-Hajj et al., 2009). Whilst these approaches 
have been successful in identifying unique functional properties and potential drug targets for 
mutant human ion channels, such as those described for mutations in sodium channel Nav1.7 
(Dib-Hajj et al., 2005; Geha et al., 2016; Yang et al., 2016), generating sensory neurons from 
patient-derived iPSCs may yet be the closet model to the human in vivo scenario. Cao and 
colleagues (Cao et al., 2016) generated iPSC from a group of patients carrying different 
mutations in Nav1.7, which results in a condition called erythromelalgia whereby patients 
experience chronic pain particularly in response to heat stimuli. Sensory neurons derived from 
different Nav1.7 mutant iPSC lines showed hyperexcitability and aberrant responses to heat, 
which is consistent with the clinical phenotypes. The Nav1.7 mutant sensory neurons were also 
used to assess efficacy of a candidate Nav1.7 channel blocker, PF-05089771, in reversing the 
neuronal hyperexcitability. Promising results were obtained, which led the authors to test the 
compound in erythromelalgia patients and similar positive findings were obtained. These 
studies are very encouraging for future developments in using hPSC-derived sensory neurons 
for disease modelling, particularly to investigate ion channel function, and assess candidate 
therapeutic compounds. 
 
 
Conclusions 
 Progress in the areas of stem cell differentiation and reprogramming are rapidly 
advancing such that the gap between comparing hPSC-derived sensory neurons and human 
DRG tissue is closing. Clearly, there are still many challenges ahead before hPSC-derived 
sensory neurons can completely model the human DRG tissue. The immense value in having 
an ongoing in vitro source of human sensory neurons outweighs current challenges we face. 
Also, rapid advancements in stem cell and reprograming technologies will inevitably address 
these current challenges. The benefits, together with the potential clinical and pharmaceutical 
applications of in vitro-derived human sensory neurons, are all strong motivating factors for 
improving methodologies to generate human sensory neurons in the culture dish. 
 
Acknowledgements 
Serena Viventi is supported by the University of Melbourne, Melbourne International Research 
Scholarship and Mirella Dottori is supported by Australian Research Council Future 
Fellowship and University of Wollongong. 
 
 
 
 
 
 
 
 
 
References  
Abraira, V.E., and Ginty, D.D. (2013). The Sensory Neurons of Touch. Neuron 79. 
Alshawaf, A.J., Viventi, S., Qiu, W., D’Abaco, G., Nayagam, B., Erlichster, M., Chana, G., 
Everall, I., Ivanusic, J., Skafidas, E., et al. (2018). Phenotypic and Functional 
Characterization of Peripheral Sensory Neurons derived from Human Embryonic Stem Cells. 
Sci. Rep. 8, 603. 
Blanchard, J.W., Eade, K.T., Szűcs, A., Lo Sardo, V., Tsunemoto, R.K., Williams, D., Sanna, 
P.P., and Baldwin, K.K. (2015). Selective conversion of fibroblasts into peripheral sensory 
neurons. Nat. Neurosci. 18, 25–35. 
Boisvert, E. M., Engle, S.J., Hallowell, S.E., Liu, P., Wang, Z.W., Li, X.J. (2015). The 
specification and maturation of nociceptive neurons from human embryonic stem cells. Sci. 
Rep. 16821. 
 
Brokhman, I., Gamarnik-Ziegler, L., Pomp, O., Aharonowiz, M., Reubinoff, B.E., and 
Goldstein, R.S. (2008). Peripheral sensory neurons differentiate from neural precursors 
derived from human embryonic stem cells. Differ. Res. Biol. Divers. 76, 145–155. 
Cai, S., Han, L., Ao, Q., Chan, Y.S., and Shum, D.K. (2017). Human induced pluripotent 
cell-derived sensory neurons for fate commitment of bone marrow-derived Schwann cells: 
implications for remyelination therapy. Stem Cells Transl Med. 6, 369-381. 
 
Cao, L., McDonnell, A., Nitzsche, A., Alexandrou, A., Saintot, P.-P., Loucif, A.J.C., Brown, 
A.R., Young, G., Mis, M., Randall, A., et al. (2016). Pharmacological reversal of a pain 
phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia. Sci. 
Transl. Med. 8, 335ra56. 
Chambers, S.M., Qi, Y., Mica, Y., Lee, G., Zhang, X.-J., Niu, L., Bilsland, J., Cao, L., 
Stevens, E., Whiting, P., et al. (2012). Combined small-molecule inhibition accelerates 
developmental timing and converts human pluripotent stem cells into nociceptors. Nat. 
Biotechnol. 30, 715–720. 
Chopra, K., and Tiwari, V. (2012). Alcoholic neuropathy: possible mechanisms and future 
treatment possibilities. Br. J. Clin. Pharmacol. 73, 348–362. 
Davidson, S., Copits, B.A., Zhang, J., Page, G., Ghetti, A., and Gereau, R.W. (2014). Human 
sensory neurons: Membrane properties and sensitization by inflammatory mediators. Pain 
155, 1861–1870. 
Delatycki, M.B., and Corben, L.A. (2012). Clinical features of Friedreich ataxia. J. Child 
Neurol. 27, 1133–1137. 
Deng, M., Yang, H., Xie, X., Liang, G., and Gan, L. (2014). Comparative expression analysis 
of POU4F1, POU4F2 and ISL1 in developing mouse cochleovestibular ganglion neurons. 
Gene Expr. Patterns GEP 15, 31–37. 
Denham, M., Hasegawa, K., Menheniott, T., Rollo, B., Zhang, D., Hough, S., Alshawaf, A., 
Febbraro, F., Ighaniyan, S., Leung, J., et al. (2015). Multipotent caudal neural progenitors 
derived from human pluripotent stem cells that give rise to lineages of the central and 
peripheral nervous system. Stem Cells Dayt. Ohio 33, 1759–1770. 
Dib-Hajj, S.D., Rush, A.M., Cummins, T.R., Hisama, F.M., Novella, S., Tyrrell, L., Marshall, 
L., and Waxman, S.G. (2005). Gain-of-function mutation in Nav1.7 in familial 
erythromelalgia induces bursting of sensory neurons. Brain J. Neurol. 128, 1847–1854. 
Dib-Hajj, S.D., Choi, J.S., Macala, L.J., Tyrrell, L., Black, J.A., Cummins, T.R., and 
Waxman, S.G. (2009). Transfection of rat or mouse neurons by biolistics or electroporation. 
Nat. Protoc. 4, 1118–1126. 
Dubin, A.E., and Patapoutian, A. (2010). Nociceptors: the sensors of the pain pathway. J. 
Clin. Invest. 120, 3760–3772. 
Dykes, I.M., Lanier, J., Eng, S.R., and Turner, E.E. (2010). Brn3a regulates neuronal subtype 
specification in the trigeminal ganglion by promoting Runx expression during sensory 
differentiation. Neural Develop. 5, 3. 
Dykes, I.M., Tempest, L., Lee, S.-I., and Turner, E.E. (2011). Brn3a and Islet1 act 
epistatically to regulate the gene expression program of sensory differentiation. J. Neurosci. 
Off. J. Soc. Neurosci. 31, 9789–9799. 
Eberhardt, E., Havlicek, S., Schmidt, D., Link, A.S., Neacsu, C., Kohl, Z., Hampl, M., Kist, 
A.M., Klinger, A., Nau, C., et al. (2015). Pattern of Functional TTX-Resistant Sodium 
Channels Reveals a Developmental Stage of Human iPSC- and ESC-Derived Nociceptors. 
Stem Cell Rep. 5, 305–313. 
Eng, S.R., Dykes, I.M., Lanier, J., Fedtsova, N., and Turner, E.E. (2007). POU-domain factor 
Brn3a regulates both distinct and common programs of gene expression in the spinal and 
trigeminal sensory ganglia. Neural Develop. 2, 3. 
Fariñas, I., Wilkinson, G.A., Backus, C., Reichardt, L.F., and Patapoutian, A. (1998). 
Characterization of Neurotrophin and Trk Receptor Functions in Developing Sensory 
Ganglia: Direct NT-3 Activation of TrkB Neurons In Vivo. Neuron 21, 325–334. 
Fleming, M.S., and Luo, W. (2013). The anatomy, function, and development of mammalian 
Aβ low-threshold mechanoreceptors. Front. Biol. 8. 
Geha, P., Yang, Y., Estacion, M., Schulman, B.R., Tokuno, H., Apkarian, A.V., Dib-Hajj, 
S.D., and Waxman, S.G. (2016). Pharmacotherapy for Pain in a Family With Inherited 
Erythromelalgia Guided by Genomic Analysis and Functional Profiling. JAMA Neurol. 73, 
659–667. 
Gilman, S. (2002). Joint position sense and vibration sense: anatomical organisation and 
assessment. J. Neurol. Neurosurg. Psychiatry 73, 473–477. 
Goldstein, R.S., Pomp, O., Brokhman, I., and Ziegler, L. (2010). Generation of neural crest 
cells and peripheral sensory neurons from human embryonic stem cells. Methods Mol. Biol. 
Clifton NJ 584, 283–300. 
Guo, X., Spradling, S., Stancescu, M., Lambert, S., and Hickman, J. (2013). Derivation of 
sensory neurons and neural crest stem cells from human neural progenitor HNP1. 
Biomaterials 34,4418-27. 
Hari, L., Brault, V., Kléber, M., Lee, H.-Y., Ille, F., Leimeroth, R., Paratore, C., Suter, U., 
Kemler, R., and Sommer, L. (2002). Lineage-specific requirements of β-catenin in neural 
crest development. J. Cell Biol. 159, 867–880. 
Henion, P.D., Garner, A.S., Large, T.H., and Weston, J.A. (1995). trkC-mediated NT-3 
signaling is required for the early development of a subpopulation of neurogenic neural crest 
cells. Dev. Biol. 172, 602–613. 
Hirschi, K.K., Li, S., and Roy, K. (2014). Induced pluripotent stem cells for regenerative 
medicine. Annu. Rev. Biomed. Eng. 16, 277–294. 
Hoelting, L., Klima, S., Karreman, C., Grinberg, M., Meisig, J., Henry, M., Rotshteyn, T., 
Rahnenführer, J., Blüthgen, N., Sachinidis, A., et al. (2016). Stem Cell-­‐‑Derived Immature 
Human Dorsal Root Ganglia Neurons to Identify Peripheral Neurotoxicants. STEM CELLS 
Transl. Med. 5, 476–487. 
Huang, S., O’Donovan, K.J., Turner, E.E., Zhong, J., and Ginty, D.D. (2015). Extrinsic and 
intrinsic signals converge on the Runx1/CBFβ transcription factor for nonpeptidergic 
nociceptor maturation. ELife 4, e10874. 
Kandel, E.R., Schwartz, J.H., Jessell, T.M., Siegelbaum, S.A., and Huspeth, A.J. (2013). 
Principle of neural science.  
 
Kim, S.-E., Kim, B.-K., Gil, J.-E., Kim, S.-K., and Kim, J.-H. (2007). Comparative analysis 
of the developmental competence of three human embryonic stem cell lines in vitro. Mol. 
Cells 23, 49–56. 
Laing, R.J., and Dhaka, A. (2016). ThermoTRPs and Pain. Neurosci. Rev. J. Bringing 
Neurobiol. Neurol. Psychiatry 22, 171–187. 
Le Pichon, C.E., and Chesler, A.T. (2014). The functional and anatomical dissection of 
somatosensory subpopulations using mouse genetics. Front. Neuroanat. 8, 21. 
Lee, K.S., Zhou, W., Scott-McKean, J.J., Emmerling, K.L., Cai, G., Krah, D.L., Costa, A.C., 
Freed, C.R., and Levin, M.J. (2012). Human Sensory Neurons Derived from Induced 
Pluripotent Stem Cells Support Varicella-Zoster Virus Infection. PLOS ONE 7, e53010. 
Li, C., Wang, S., Chen, Y., and Zhang, X. (2017). Somatosensory Neuron Typing with High-
Coverage Single-Cell RNA Sequencing and Functional Analysis. Neurosci. Bull. 1–8. 
Li, C.-L., Li, K.-C., Wu, D., Chen, Y., Luo, H., Zhao, J.-R., Wang, S.-S., Sun, M.-M., Lu, Y.-
J., Zhong, Y.-Q., et al. (2016). Somatosensory neuron types identified by high-coverage 
single-cell RNA-sequencing and functional heterogeneity. Cell Res. 26, 83–102. 
Liebl, D.J., Tessarollo, L., Palko, M.E., and Parada, L.F. (1997). Absence of sensory neurons 
before target innervation in brain-derived neurotrophic factor-, neurotrophin 3-, and TrkC-
deficient embryonic mice. J. Neurosci. Off. J. Soc. Neurosci. 17, 9113–9121. 
Lim, T.K.Y., Rone, M.B., Lee, S., Antel, J.P., and Zhang, J. (2015). Mitochondrial and 
bioenergetic dysfunction in trauma-induced painful peripheral neuropathy. Mol. Pain 11, 58. 
Luo, W., Wickramasinghe, S.R., Savitt, J.M., Griffin, J.W., Dawson, T.M., and Ginty, D.D. 
(2007). A hierarchical NGF signaling cascade controls Ret-dependent and Ret-independent 
events during development of nonpeptidergic DRG neurons. Neuron 54, 739–754. 
Ma, Q., Fode, C., Guillemot, F., and Anderson, D.J. (1999). NEUROGENIN1 and 
NEUROGENIN2 control two distinct waves of neurogenesis in developing dorsal root 
ganglia. Genes Dev. 13, 1717–1728. 
Mandge, D., and Manchanda, R. (2015). Computational studies on bladder small dorsal root 
ganglion neurons: Modelling BK channels. Conf. Proc. Annu. Int. Conf. IEEE Eng. Med. 
Biol. Soc. IEEE Eng. Med. Biol. Soc. Annu. Conf. 2015, 5376–5379. 
Manji, H. (2011). Toxic neuropathy. Curr. Opin. Neurol. 24, 484–490. 
Melli, G., and Höke, A. (2009). Dorsal Root Ganglia Sensory Neuronal Cultures: a tool for 
drug discovery for peripheral neuropathies. Expert Opin. Drug Discov. 4, 1035–1045. 
Osafune, K., Caron, L., Borowiak, M., Martinez, R.J., Fitz-Gerald, C.S., Sato, Y., Cowan, 
C.A., Chien, K.R., and Melton, D.A. (2008). Marked differences in differentiation propensity 
among human embryonic stem cell lines. Nat. Biotechnol. 26, 313–315. 
Pal, R., Totey, S., Mamidi, M.K., Bhat, V.S., and Totey, S. (2009). Propensity of human 
embryonic stem cell lines during early stage of lineage specification controls their terminal 
differentiation into mature cell types. Exp. Biol. Med. Maywood NJ 234, 1230–1243. 
Pomp, O., Brokhman, I., Ziegler, L., Almog, M., Korngreen, A., Tavian, M., and Goldestein, 
R.S. (2008). PA6-Induced human embryonic stem cell-derived neurospheres: a new source of 
human peripheral sensory neurons and neural crest cells. Brain Research 1230, 50-60. 
 
Proske, U., and Gandevia, S.C. (2012). The proprioceptive senses: their roles in signaling 
body shape, body position and movement, and muscle force. Physiol. Rev. 92, 1651–1697. 
Raible, D.W., and Ungos, J.M. (2006). Specification of Sensory Neuron Cell Fate from the 
Neural Crest. In Neural Crest Induction and Differentiation, (Springer, Boston, MA), pp. 
170–180. 
Rosenbaum, T., Awaya, M., and Gordon, S.E. (2002). Subunit modification and association 
in VR1 ion channels. BMC Neurosci. 3, 4. 
Rostock, C., Schrenk-Siemens, K., Pohle, J., and Siemens, J. (2017). Human vs. Mouse 
Nociceptors - Similarities and Differences. Neuroscience. 
Samad, O.A., Liu, Y., Yang, F.-C., Kramer, I., Arber, S., and Ma, Q. (2010). Characterization 
of two Runx1-dependent nociceptor differentiation programs necessary for inflammatory 
versus neuropathic pain. Mol. Pain 6, 45. 
Sangameswaran, L., Delgado, S.G., Fish, L.M., Koch, B.D., Jakeman, L.B., Stewart, G.R., 
Sze, P., Hunter, J.C., Eglen, R.M., and Herman, R.C. (1996). Structure and Function of a 
Novel Voltage-gated, Tetrodotoxin-resistant Sodium Channel Specific to Sensory Neurons. J. 
Biol. Chem. 271, 5953–5956. 
Schrenk-Siemens, K., Wende, H., Prato, V., Song, K., Rostock, C., Loewer, A., Utikal, J., 
Lewin, G.R., Lechner, S.G., and Siemens, J. (2015). PIEZO2 is required for 
mechanotransduction in human stem cell-derived touch receptors. Nat. Neurosci. 18, 10–16. 
de Schryver, E.L.L.M., van Schelven, L.J., Notermans, N.C., de Valk, H.W., and Oey, P.L. 
(2011). Small-fibre neuropathy can be detected in patients with chronic idiopathic axonal 
polyneuropathy. Eur. J. Neurol. 18, 1003–1005. 
Schütz, S.G., and Robinson-Papp, J. (2013). HIV-related neuropathy: current perspectives. 
HIVAIDS Auckl. NZ 5, 243–251. 
Sederholm, B.H. (2010). Treatment of acute immune-mediated neuropathies: Guillain-Barré 
syndrome and clinical variants. Semin. Neurol. 30, 365–372. 
Serrano, A., Mo, G., Grant, R., Paré, M., O’Donnell, D., Yu, X.H., Tomaszewski, M.J., 
Perkins, M.N., Séguéla, P., and Cao, C.Q. (2012). Differential expression and pharmacology 
of native P2X receptors in rat and primate sensory neurons. J. Neurosci. Off. J. Soc. 
Neurosci. 32, 11890–11896. 
Shimizu, S., Ichikawa, H., Nakagawa, H., Kiyomiya, K., and Matsuo, S. (2007). Effect of 
BDNF depletion on the formation of Ruffini endings in vibrissa follicles and the survival of 
their mechanoreceptive neurons in trigeminal ganglion. Brain Res. 1154, 95–104. 
Stacey, P., Wassermann, A.M., Kammonen, L., Impey, E., Wilbrey, A., and Cawkill, D. 
(2018). Plate-Based Phenotypic Screening for Pain Using Human iPSC-Derived Sensory 
Neurons. SLAS Discov. Adv. Life Sci. R D 2472555218764678. 
Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse 
embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676. 
Tessarollo, L., Tsoulfas, P., Donovan, M.J., Palko, M.E., Blair-Flynn, J., Hempstead, B.L., 
and Parada, L.F. (1997). Targeted deletion of all isoforms of the trkC gene suggests the use 
of alternate receptors by its ligand neurotrophin-3 in neuronal development and implicates 
trkC in normal  cardiogenesis. Proc. Natl. Acad. Sci. U. S. A. 94, 14776–14781. 
Trezise, D.J., John, V.H., and Xie, X.M. (1998). Voltage- and use-dependent inhibition of 
Na+ channels in rat sensory neurones by 4030W92, a new antihyperalgesic agent. Br. J. 
Pharmacol. 124, 953–963. 
Usoskin, D., Furlan, A., Islam, S., Abdo, H., Lönnerberg, P., Lou, D., Hjerling-Leffler, J., 
Haeggström, J., Kharchenko, O., Kharchenko, P.V., et al. (2015a). Unbiased classification of 
sensory neuron types by large-scale single-cell RNA sequencing. Nat. Neurosci. 18, 145–
153. 
Usoskin, D., Furlan, A., Islam, S., Abdo, H., Lönnerberg, P., Lou, D., Hjerling-Leffler, J., 
Haeggström, J., Kharchenko, O., Kharchenko, P.V., et al. (2015b). Unbiased classification of 
sensory neuron types by large-scale single-cell RNA sequencing. Nat. Neurosci. 18, 145–
153. 
Valeyev, A.Y., Hackman, J.C., Wood, P.M., and Davidoff, R.A. (1996). Pharmacologically 
novel GABA receptor in human dorsal root ganglion neurons. J. Neurophysiol. 76, 3555–
3558. 
Valtcheva, M.V., Copits, B.A., Davidson, S., Sheahan, T.D., Pullen, M.Y., McCall, J.G., 
Dikranian, K., and Gereau, R.W. (2016). Surgical extraction of human dorsal root ganglia 
from organ donors and preparation of primary sensory neuron cultures. Nat. Protoc. 11, 
1877–1888. 
Wainger, B.J., Buttermore, E.D., Oliveira, J.T., Mellin, C., Lee, S., Saber, W.A., Wang, A.J., 
Ichida, J.K., Chiu, I.M., Barrett, L., et al. (2015). Modeling pain in vitro using nociceptor 
neurons reprogrammed from fibroblasts. Nat. Neurosci. 18, 17–24. 
Yang, Y., Huang, J., Mis, M.A., Estacion, M., Macala, L., Shah, P., Schulman, B.R., Horton, 
D.B., Dib-Hajj, S.D., and Waxman, S.G. (2016). Nav1.7-A1632G Mutation from a Family 
with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by 
Thermal Stimuli. J. Neurosci. Off. J. Soc. Neurosci. 36, 7511–7522. 
d’Ydewalle, C., Benoy, V., and Van Den Bosch, L. (2012). Charcot-Marie-Tooth disease: 
emerging mechanisms and therapies. Int. J. Biochem. Cell Biol. 44, 1299–1304. 
Young, G.T., Gutteridge, A., Fox, H.D., Wilbrey, A.L., Cao, L., Cho, L.T., Brown, A.R., 
Benn, C.L., Kammonen, L.R., Friedman, J.H., et al. (2014). Characterizing human stem cell-
derived sensory neurons at the single-cell level reveals their ion channel expression and 
utility in pain research. Mol. Ther. J. Am. Soc. Gene Ther. 22, 1530–1543. 
Zhang, X., and Bao, L. (2006). The development and modulation of nociceptive circuitry. 
Curr. Opin. Neurobiol. 16, 460–466. 
Zhang, X., Priest, B.T., Belfer, I., and Gold, M.S. (2017). Voltage-gated Na+ currents in 
human dorsal root ganglion neurons. ELife 6, e23235. 
Zimmerman, A., Bai, L., and Ginty, D.D. (2014). The gentle touch receptors of mammalian 
skin. Science 346, 950–954. 
Zou, M., Li, S., Klein, W.H., and Xiang, M. (2012). Brn3a/Pou4f1 Regulates Dorsal Root 
Ganglion Sensory Neuron Specification and Axonal Projection into the Spinal Cord. Dev. 
Biol. 364, 114–127. 
Zylka, M.J., Dong, X., Southwell, A.L., and Anderson, D.J. (2003). Atypical expansion in 
mice of the sensory neuron-specific Mrg G protein-coupled receptor family. Proc. Natl. 
Acad. Sci. U. S. A. 100, 10043–10048. 
 
 
   
 
 
   
Figure Legend 
 
Figure 1. Different approaches for generating human sensory neurons in vitro. 
Differentiation of human ESC and iPSC either via neural crest progenitor (A) or directly (B) 
to sensory neuronal lineage. An alternative approach is direct reprogramming of fibroblasts to 
sensory neurons (C). 
 
 
 
 
                             
Table 1. Summary of main publications to date that describe generation of DRG sensory 
neurons from hPSC. 
Paper Differentiation 
factors 
DRG subtypes Characterization 
Pomp et al., 2008 
Brain Research  
bFGF, NIM, NGF, 
BDNF, NT-3   
Nociceptors Immunostainings 
Q-PCR 
Electrophysiology 
(patch-clamp) 
Chambers et al., 2012 
Nature Biotechnology 
SB431542, LDN-
193189, SU5402, 
CHIR99021, DAPT, 
NGF, BDNF, GDNF  
Nociceptors Immunostainings 
Flow cytometry 
Microarray analysis 
Electrophysiology 
(Patch-clamp) 
Calcium Imaging 
Lee et al., 2012  
Plos One 
SU5402, 
RO4929097, 
CHIR99021, A83-01, 
LDN-193189,  
NT-3, BDNF, NGF, 
GDNF, ascorbic acid, 
dibutyryl cAMP 
Pan-sensory 
neuronal markers 
Immunostainings 
Flow Cytometry 
Electrophysiology 
(patch-clamp) 
Guo et al., 2013 
Biomaterials  
Noggin, SB431542, 
Wnt1, bFGF, hEGF,  
BDNF, NT-3, GDNF, 
NGF, cAMP, ascorbic 
acid 
Pan-sensory 
neuronal markers 
and proprioceptors 
Immunostainings 
Electrophysiology 
(patch-clamp) 
Young et al., 2014 
Mol. Ther. 
SB431542, LDN-
193189, SU5402, 
CHIR99021, DAPT, 
NGF, BDNF, GDNF,  
ascorbic acid 
Nociceptors Immunostainings 
Q-PCR 
Microarray 
Single-cell Q-PCR 
Electrophysiology  
(patch-clamp) 
Blanchard et al., 2015  
Nature Neuroscience 
Inducible lentiviral: 
Brn3A/NGN1 (BN1)  
Brn3A/NGN2 (BN2) 
Nociceptors 
Mechanoreceptors  
Proprioceptors 
Immunostaining,  
Electrophysiology 
(Patch-clamp) 
Calcium Imaging 
Boisvert et al., 2015 
Scientific Report 
NIM (neural 
induction media), 
bFGF, heparin, cAMP 
RA, BMP4 
+ 
Inducible lentivirus 
Nociceptors Immunostainings 
Q-PCR 
Calcium Imaging 
Electrophysiology 
(Patch-clamp) 
Denham et al., 2015 
Stem Cells 
SB431542, 
CHIR999021, BMP2,  
FGF2, diff media 
Pan-sensory 
neuronal markers 
Immunostainings 
FACS 
Q-PCR 
Eberhardt et al., 2015 
Stem Cell Reports 
LDN-193189, 
SB431542, 
CHIR99021, 
SU5402, DAPT, 
human-b-NGF, 
BDNF, GDNF, 
ascorbic acid 
Nociceptors Immunostainings 
Q-PCR 
Electrophysiology 
(patch-clamp) 
 
Schrenk-Siemens et 
al., 2015 
Nature Neuroscience 
FGF, EGF, NGF, NT-
3, BDNF, GDNF, RA 
+  
Inducible lentivirus: 
NGN2 
Mechanoreceptors Immunostainings 
In situ hybridization 
Q-PCR  
Deep-sequencing 
analysis 
Electrophysiology  
(patch-clamp) 
Calcium Imaging 
Generation of 
PIEZO2 Knockout 
hES cells 
Generation of hiPS 
cells 
Wainger et al., 2015 
Nature Neuroscience 
Retroviruses for 5 
transcription factors: 
Ascl1, Myt1l, Ngn1, 
Isl2, Klf7 
+ 
FGF, BDNF, CNTF, 
GDNF, NGF 
Nociceptors Immunostainings 
Electrophysiology 
(patch-clamp) 
Cao et al., 2016 
Sci. Transl. Med. 
SB431642, LDN-
193189, CHIR99021, 
SU5402, DAPT, NT-
3, GDNF, BDNF, 
NGF, ascorbic acid 
Nociceptors Immunostainings 
Q-PCR 
Electrophysiology 
(patch-clamp) 
 
Hoelting et al., 2016 
Stem Cells Transl. 
Med. 
Noggin, 
dorsomorphin, 
SB431642, 
CHIR99021, 
SU5402, DAPT, Y-
27632, b-
mercaptoethanol, 
FGF, BDNG, NGF, 
GDNF 
Pan-sensory 
neuronal markers, 
Nociceptors 
Immunostainings 
PeriTox test 
Q-PCR 
 
Cai et al., 2017 
Stem  
Cells Translational 
Medicine 
LDN-193189, A83-
01, CHIR99021, 
RO4929097, 
SU5402, RA, NT-3, 
NGF, BDNF, GDNF 
Pan-sensory 
neuronal marker 
Immunostainings 
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